Michael A. Metzger - Jul 25, 2022 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Jul 25, 2022
Transactions value $
-$463,772
Form type
4
Date filed
7/27/2022, 06:42 PM
Previous filing
Jul 11, 2022
Next filing
Oct 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $126K +19.8K +111.92% $6.38 37.4K Jul 25, 2022 Direct
transaction SNDX Common Stock Sale -$416K -19.8K -52.81% $21.06 17.7K Jul 25, 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $75.5K +11.8K +67.04% $6.38 29.5K Jul 25, 2022 Direct
transaction SNDX Common Stock Sale -$249K -11.8K -40.13% $21.06 17.7K Jul 25, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -19.8K -100% $0.00* 0 Jul 25, 2022 Common Stock 19.8K $6.38 Direct F3
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -11.8K -100% $0.00* 0 Jul 25, 2022 Common Stock 11.8K $6.38 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 670,466 options to purchase shares of common stock that are vested and immediately exercisable and a total of 539,063 options to purchase shares of common stock that have not yet vested.
F2 The sale prices ranged from $21.00 to $21.16.
F3 This option vests in 48 successive equal monthly installments measured from 02/06/2019.
F4 This option vests periodically upon the Issuer achieving certain milestones.